Trial Profile
An Oral, Rising, Multiple-Dose Tolerance, Pharmacokinetic and Pharmacodynamic Study of Gemcabene Capsules in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Gemcabene (Primary)
- Indications Hypercholesterolaemia; Hyperlipoproteinaemia; Hypertension; Hypertriglyceridaemia; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Osteoarthritis
- Focus Pharmacokinetics
- Sponsors Gemphire Therapeutics
- 15 Sep 2016 New trial record